Eli Lilly Issues Warning About Fake Weight-Loss Drugs from amala fakes Watch Video
Preview(s): Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Your browser does not support playing the video.Please download the video!
⏲ Duration: 1:31 👁 View: 390K times ✓ Published: 21-Jun-2024
Description: Eli Lilly Issues Warning , About Fake Weight-Loss Drugs.<br/>On June 20, Eli Lilly published an open letter, <br/>warning about fake and compounded versions <br/>of Mounjaro and Zepbound, ABC News reports. .<br/>Lilly is committed to making life better <br/>for people living with diabetes and <br/>obesity through developing medicines <br/>that change the way healthcare <br/>providers can treat these diseases, Eli Lilly, via open letter.<br/>Lilly Stands Against the Use of its <br/>Medicines for Cosmetic Weight Loss, Eli Lilly, via open letter.<br/>The company went on to advise consumers to stay away from buying weight-loss drugs online without a prescription. .<br/>Lilly is deeply concerned about <br/>the proliferation of online sales <br/>and posts on social media involving <br/>counterfeit, fake, compounded, <br/>and any other unsafe or untested <br/>versions of what they say is tirzepatide, Eli Lilly, via open letter.<br/>Any products marketed simply as <br/>“tirzepatide” (as opposed to <br/>Mounjaro® and Zepbound®) were <br/>not made by, studied by, or sold by <br/>Lilly and are not FDA-approved. , Eli Lilly, via open letter.<br/>Be aware that when you purchase <br/>products that are not FDA-approved <br/>medicines or obtain medicines from <br/>an unverified source or without a prescription <br/>from a licensed healthcare provider, <br/>you may be purchasing fake, counterfeit, <br/>or otherwise unsafe products. , Eli Lilly, via open letter.<br/>Eli Lilly also addressed concerns about compounded medications.<br/>Although compounding is legal amid <br/>drug shortages, the FDA has shared <br/>concerns about substandard products. .<br/>Eli Lilly says that it has tested some compounded versions of its products, <br/>only to find safety and efficacy issues.<br/>Some products had high bacteria counts <br/>and impurities, while others were <br/>entirely different chemical structures.